Patterns of Opioid Use and Risk of Opioid Overdose Death Among Medicaid Patients

Medical Care

Volumn 55, Issue 7, 2017, Pages 661-668

  Garg, Renu K ^a   Fulton Kehoe, Deborah ^a   Franklin, Gary M ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b WASHINGTON STATE DEPARTMENT OF LABOR AND INDUSTRIES   (United States)

Author keywords

chronic pain; Medicaid; opioid; overdose

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CODEINE; DEXTROPROPOXYPHENE NAPSILATE; FENTANYL; HYDROMORPHONE; HYPNOTIC SEDATIVE AGENT; METHADONE; MORPHINE; MUSCLE RELAXANT AGENT; OPIATE; TRAMADOL; NARCOTIC ANALGESIC AGENT;

ADULT; ANALGESIA; ARTICLE; CAUSE OF DEATH; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH CERTIFICATE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG OVERDOSE; DRUG USE; FEMALE; FOLLOW UP; HUMAN; HYPNOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MIDDLE AGED; MORTALITY RISK; OPIATE ADDICTION; PAIN; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEDATION; SHORT COURSE THERAPY; SKELETAL MUSCLE; TRANSDERMAL DRUG ADMINISTRATION; YOUNG ADULT; ADOLESCENT; CHRONIC PAIN; EPIDEMIOLOGY; MORTALITY; RISK ASSESSMENT; UNITED STATES;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; CHRONIC PAIN; DRUG OVERDOSE; FEMALE; HUMANS; MALE; MEDICAID; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; UNITED STATES; YOUNG ADULT;

EID: 85021332163     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0000000000000738     Document Type: Article

References (50)

1. Paulozzi LJ, Jones CM, Mack K, et al. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR Morb Mortal Wkly Rep. 2011;60:1487-1492.
2. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain. 2004;109:514-519.
3. Brixner DI, Oderda GM, Roland CL, et al. Opioid expenditures and utilization in the Medicaid system. J Pain Palliat Care Pharmacother. 2006;20:5-13.
4. Franklin GM, Mai J, Turner J, et al. Bending the prescription opioid dosing and mortality curves: impact of the Washington State opioid dosing guideline. Am J Ind Med. 2012;55:325-331.
5. Kenan K, Mack K, Paulozzi L. Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000-2010. Open Med. 2012;6:41-47.
6. Volkow ND. Prescription opioid and heroin abuse. National Institute on Drug Abuse: presented to the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations. 2014. Available at: www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2015/prescription-opioid-heroin-abuse. Accessed August 8, 2015.
7. Bloodworth D. Opioids in the treatment of chronic pain: legal framework and therapeutic indications and limitations. Phys Med Rehabil Clin N Am. 2006;17:355-379.
8. Daubresse M, Chang HY, Yu Y, et al. Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010. Med Care. 2013;51:870-878.
9. Warner M, Hedegaard H, Chen LH. Trends in drug-poisoning deaths involving opioid analgesics and heroin: United States, 1999-2012. NCHS Health E-Stat. 2014. Available at: www.cdc.gov/nchs/data/hestat/drug-poisoning/drug-poisoning.htm#sources. Accessed July 1, 2015.
10. Paulozzi LJ, Baldwin G, Franklin G, et al. CDC grand rounds: prescription drug overdoses-a US epidemic. MMWR Morb Mortal Wkly Rep. 2012;61:10-13.
11. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 2016;315:1624-1645.
12. Chou R, Ballantyne JC, Fanciullo GJ, et al. Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10:147-159.
13. Chapman CR, Lipschitz DL, Angst MS, et al. Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J Pain. 2010;11:807-829.
14. Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162:276-286.
15. Coolen P, Best S, Lima A, et al. Overdose deaths involving prescription opioids among Medicaid enrollees-Washington, 2004-2007. MMWR Morb Mortal Wkly Rep. 2009;58:1171-1175.
16. Mack KA, Zhang K, Paulozzi L, et al. Prescription practices involving opioid analgesics among Americans with Medicaid, 2010. J Health Care Poor Underserved. 2015;26:182-198.
17. Zerzan JT, Morden NE, Soumerai S, et al. Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care. 2006;44:1005-1010.
18. Morden NE, Zerzan JT, Rue TC, et al. Medicaid prior authorization and controlled-release oxycodone. Med Care. 2008;46:573-580.
19. Stein BD, Gordon AJ, Sorbero M, et al. The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone. Drug Alcohol Depend. 2012;123:72-78.
20. Ringwalt C, Roberts AW, Gugelmann H, et al. Racial disparities across provider specialties in opioid prescriptions dispensed to Medicaid beneficiaries with chronic noncancer pain. Pain Med. 2015;16: 633-640.
21. Yang Z, Wilsey B, Bohm M, et al. Defining risk of prescription opioid overdose: pharmacy shopping and overlapping prescriptions among long-term opioid users in medicaid. J Pain. 2015;16:445-453.
22. Ray WA, Chung CP, Murray KT, et al. Prescription of long-acting opioids and mortality in patients with chronic noncancer pain. JAMA. 2016;315:2415-2423.
23. Ray WA, Chung CP, Murray KT, et al. Out-of-hospital mortality among patients receiving methadone for noncancer pain. JAMA Intern Med. 2015;175:420-427.
24. Hartung DM, Middleton L, Haxby DG, et al. Rates of adverse events of long-acting opioids in a state Medicaid program. Ann Pharmacother. 2007;41:921-928.
25. Ray WA, Murray KT, Kawai V, et al. Propoxyphene and the risk of out-of-hospital death. Pharmacoepidemiol Drug Saf. 2013;22:403-412.
26. Braden JB, Russo J, Fan MY, et al. Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med. 2010;170: 1425-1432.
27. Dilokthornsakul P, Moore G, Campbell JD, et al. Risk factors of prescription opioid overdose among Colorado Medicaid beneficiaries. J Pain. 2016;17:436-443.
28. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152: 85-92.
29. Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011; 305:1315-1321.
30. Gomes T, Mamdani MM, Dhalla IA, et al. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171:686-691.
31. Dasgupta N, Funk MJ, Proescholdbell S, et al. Cohort study of the impact of high-dose opioid analgesics on overdose mortality. Pain Med. 2016;17:85-98.
32. Zedler B, Xie L, Wang L, et al. Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients. Pain Med. 2014;15:1911-1929.
33. Cochran G, Gordon AJ, Lo-Ciganic WH, et al. An examination of claims-based predictors of overdose from a large Medicaid program. Med Care. 2017;55:291-298.
34. Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18:1166-1175.
35. Chen LH, Hedegaard H, Warner M. Drug-poisoning deaths involving opioid analgesics: United States, 1999-2011. NCHS Data Brief. 2014;166:1-8.
36. Jones CM, McAninch JK. Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines. Am J Prev Med. 2015;49:493-501.
37. Miller M, Barber CW, Leatherman S, et al. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA Intern Med. 2015;175:608-615.
38. Von Korff M, Saunders K, Ray GT, et al. De facto long-term opioid therapy for noncancer pain. Clin J Pain. 2008;24:521-527.
39. Washington State Agency Medical Directors' Group. Interagency Guideline on Opioid Dosing for Chronic Non-Cancer Pain. Olympia, WA:Washington State Agency Medical Directors' Group; 2015. Available at: www.agencymeddirectors.wa.gov/opioiddosing.asp. Accessed August 22, 2015.
40. Nielsen S, Degenhardt L, Hoban B, et al. A synthesis of oral morphine equivalents (OME) for opioid utilisation studies. Pharmacoepidemiol Drug Saf. 2016;25:733-737.
41. Edlund MJ, Martin BC, Russo JE, et al. The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription. Clin J Pain. 2014;30:557-564.
42. Dufour R, Joshi AV, Pasquale MK, et al. The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations. Pain Pract. 2014;14:E106-E115.
43. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130-1139.
44. StataCorp. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP; 2011.
45. Bohnert AS, Logan JE, Ganoczy D, et al. A detailed exploration into the association of prescribed opioid dosage and overdose deaths among patients with chronic pain. Med Care. 2016;54:435-441.
46. Gwira Baumblatt JA, Wiedeman C, Dunn JR, et al. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Intern Med. 2014;174:796-801.
47. Chou R, Deyo R, Friedly J, et al. Noninvasive Treatments for Low Back Pain. Comparative Effectiveness Review No. 169. Rockville, MD: Agency for Healthcare Research and Quality; 2016.
48. Friedman BW, Dym AA, Davitt M, et al. Naproxen with cyclobenzaprine, oxycodone/acetaminophen, or placebo for treating acute low back pain: a randomized clinical trial. JAMA. 2015;314:1572-1580.
49. Krebs EE, Becker WC, Zerzan J, et al. Comparative mortality among Department of Veterans Affairs patients prescribed methadone or longacting morphine for chronic pain. Pain. 2011;152:1789-1795.
50. Fulton-Kehoe D, Sullivan MD, Turner JA, et al. Opioid poisonings in Washington State Medicaid: trends, dosing, and guidelines. Med Care. 2015;53:679-685.